Myasthenia gravis
Autoimmune disease resulting in skeletal muscle weakness
Ratings
0
Nobody has rated this yet. Be the first!
Influences rating
Influences rating
Subject of
15
Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis: Results of a Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial
Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America
Myasthenia gravis: familial occurrence. A study of 1100 myasthenia gravis patients
Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome
Myasthenia gravis
Corrigendum to “Hsp60 and AChR cross-reactivity in myasthenia gravis: An update.” [J. Neurol. Sci. 292 (2010) 117–118]
Hsp60 and AChR cross-reactivity in myasthenia gravis: An update
Multidisciplinary treatment for prepubertal juvenile myasthenia gravis with crisis
Eosinophilia, myositis, and myasthenia gravis associated with a thymoma
NEONATAL MYASTHENIA GRAVIS